The evasive nature of drug efficacy: implications for drug discovery
Top Cited Papers
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 28 (8) , 423-430
- https://doi.org/10.1016/j.tips.2007.06.005
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Distinct Signaling Profiles of β1 and β2 Adrenergic Receptor Ligands toward Adenylyl Cyclase and Mitogen-Activated Protein Kinase Reveals the Pluridimensionality of EfficacyMolecular Pharmacology, 2006
- Multiplexed and microparticle‐based analyses: Quantitative tools for the large‐scale analysis of biological systemsCytometry Part A, 2006
- Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discoveryTrends in Pharmacological Sciences, 2006
- New Concepts in Drug Discovery: Collateral Efficacy and Permissive AntagonismNature Reviews Drug Discovery, 2005
- Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell-Based ModelsASSAY and Drug Development Technologies, 2004
- Activation-independent Parathyroid Hormone Receptor Internalization Is Regulated by NHERF1 (EBP50)Journal of Biological Chemistry, 2003
- Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic ReceptorJournal of Biological Chemistry, 2001
- Fluorescent Labeling of Purified β2 Adrenergic ReceptorPublished by Elsevier ,1995
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995